Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1476-5551

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells ; day:7 ; month:4 ; year:2018 ; pages:1-5
Leukemia ; (7.4.2018), 1-5

Creator: Casado, Pedro

Contributor: Wilkes, Edmund H.
Miraki-Moud, Farideh
Hadi, Marym Mohammad
Rio-Machin, Ana
Rajeeve, Vinothini
Pike, Rebecca
Iqbal, Sameena
Marfa, Santiago
Lea, Nicholas
Best, Steven
Gribben, John
Fitzgibbon, Jude
Cutillas, Pedro
SpringerLink (Online service)

DOI: 10.1038/s41375-018-0032-1

URN: urn:nbn:de:101:1-2018061122065134446786

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:31 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Casado, Pedro
Wilkes, Edmund H.
Miraki-Moud, Farideh
Hadi, Marym Mohammad
Rio-Machin, Ana
Rajeeve, Vinothini
Pike, Rebecca
Iqbal, Sameena
Marfa, Santiago
Lea, Nicholas
Best, Steven
Gribben, John
Fitzgibbon, Jude
Cutillas, Pedro
SpringerLink (Online service)

Other Objects (12)

A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1

Protein kinase inhibitors for acute leukemia

Proteomic discovery of host kinase signaling in bacterial infections

Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma

A proteomic screen of Ty1 integrase partners identifies the protein kinase CK2 as a regulator of Ty1 retrotransposition

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors

Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

Phosphoproteomic screening identifies physiological substrates of the CDKL 5 kinase

Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling

TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia

Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1

Protein kinase inhibitors for acute leukemia

Proteomic discovery of host kinase signaling in bacterial infections

Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma

A proteomic screen of Ty1 integrase partners identifies the protein kinase CK2 as a regulator of Ty1 retrotransposition

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors

Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

Phosphoproteomic screening identifies physiological substrates of the CDKL 5 kinase

Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling

TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia

Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1

Protein kinase inhibitors for acute leukemia

Proteomic discovery of host kinase signaling in bacterial infections

Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma

A proteomic screen of Ty1 integrase partners identifies the protein kinase CK2 as a regulator of Ty1 retrotransposition

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors

Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

Phosphoproteomic screening identifies physiological substrates of the CDKL 5 kinase

Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling

TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia

Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Proteomic and genomic integration identifies kinase and differentiation determinants of kinase inhibitor sensitivity in leukemia cells

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1

Protein kinase inhibitors for acute leukemia

Proteomic discovery of host kinase signaling in bacterial infections

Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma

A proteomic screen of Ty1 integrase partners identifies the protein kinase CK2 as a regulator of Ty1 retrotransposition

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors

Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

Phosphoproteomic screening identifies physiological substrates of the CDKL 5 kinase

Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling

TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia

Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1

Protein kinase inhibitors for acute leukemia

Proteomic discovery of host kinase signaling in bacterial infections

Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma

A proteomic screen of Ty1 integrase partners identifies the protein kinase CK2 as a regulator of Ty1 retrotransposition

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors

Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

Phosphoproteomic screening identifies physiological substrates of the CDKL 5 kinase

Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling

TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia

Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

A phospho-proteomic screen identifies substrates of the checkpoint kinase Chk1

Protein kinase inhibitors for acute leukemia

Proteomic discovery of host kinase signaling in bacterial infections

Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma

A proteomic screen of Ty1 integrase partners identifies the protein kinase CK2 as a regulator of Ty1 retrotransposition

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors

Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNA

Phosphoproteomic screening identifies physiological substrates of the CDKL 5 kinase

Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling

TMT-based comprehensive proteomic profiling identifies serum prognostic signatures of acute myeloid leukemia

Proteomic Profiling of Acute Promyelocytic Leukemia Identifies Two Protein Signatures Associated with Relapse

Tyrosine Kinase Inhibitor Sequencing in Patients with Chronic Myeloid Leukemia

Related objects

Reset password